Asia Pacific takes lead in cell and gene clinical trials

The Asia Pacific (APAC) region has taken in the lead in cell and gene clinical trials, accounting for the largest share ...

September 15, 2022 | Thursday | News
Innovation programme to address unmet medical needs in Victoria

University of Melbourne, Australia is expanding its Innovation Acceleration Programme (IAP) into regional Victoria, ...

September 15, 2022 | Thursday | News
China-based startup Antengene accelerates expansion in APAC region

Antengene, a biopharmaceutical startup founded in China, recently unveiled a new office space situated in Melbourne, Aus...

September 14, 2022 | Wednesday | News
Australia explores use of vaccinia virus-based vaccines to fight monkeypox

New research suggests recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the m...

September 13, 2022 | Tuesday | News
Australia's Nutromics raises $14 M for ground-breaking wearable diagnostic platform

Australia-based medtech startup Nutromics has raised an additional $14 million for its wearable diagnostic platform...

September 12, 2022 | Monday | News
Australia designs molecule chip for modern manufacturing of drug, vaccines

Australia's University of Queensland (UQ) researchers have pioneered a new chemical process to manufacture the molecules...

September 8, 2022 | Thursday | News
Australia boosts availability of digitally enabled medical technologies

ANDHealth, Australia’s leading digital health commercialisation organisation, in partnership with the Victorian Go...

September 9, 2022 | Friday | News
Australian startup OccuRx secures $16 M to progress therapies for inflammation, fibrosis

Australian biotech startup OccuRx has announcesd a $16 million cash injection to progress into clinical phase studies fo...

September 7, 2022 | Wednesday | News
Global pandemic therapeutics centre to open in Australia

The establishment of the Cumming Global Centre for Pandemic Therapeutics has been announced by the University of Melbour...

September 5, 2022 | Monday | News
Monash University receives $10.8 M grants for COVID-19 research in Australia

Three Monash University projects have received $10.8 million from the Medical Research Future Fund (MRFF) to support res...

September 6, 2022 | Tuesday | News
Australia announces historic $478 M investment to change healthcare

The University of Sydney has announced its largest ever capital investment, a landmark $478 million to build a nation-...

September 2, 2022 | Friday | News
Swiss firm Helsinn Healthcare expands footprint in Asia and Middle East

Swiss firm Helsinn Group and Singapore's Juniper Biologics Pte Ltd, a science-led healthcare company focused on research...

September 2, 2022 | Friday | News
Dr Glenn Haifer and Ampersand Capital Partners acquire Australian biologics CDMO Luina Bio

AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr Gle...

September 1, 2022 | Thursday | News
Australia develops AI model to help epilepsy patients become seizure-free

A study led by Monash University in Australia and believed to be a world first has demonstrated that an Artificial Intel...

September 1, 2022 | Thursday | News
Australia to focus research on five virus families likely to cause future pandemics

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency,...

August 30, 2022 | Tuesday | News
Pfizer emerges as leading company in Asia for COVID-19 response

Pfizer has been ranked first in its COVID-19 response, patient centricity, patient safety and bringing innovative, high-...

August 27, 2022 | Saturday | News
Some cancer immunotherapy treatments may damage fertility: Australian study

Researchers from Monash University, Australia have discovered that some immunotherapy treatments used to treat cancer ca...

August 29, 2022 | Monday | News
Australia cracks down on counterfeit drugs

The Therapeutic Goods Administration (TGA) led Australia's participation in INTERPOL's Operation Pangea, which tackles t...

August 26, 2022 | Friday | News
Australia opens first dedicated children's immunotherapy centre

Australia’s first dedicated children’s immunotherapy centre will investigate treatments to not only increase...

August 25, 2022 | Thursday | News
Alterity Therapeutics opens first site in Europe for drug trial of Multiple System Atrophy

Australia-based Alterity Therapeutics has announced that the company’s Phase 2 clinical trial of ATH434 for ...

August 25, 2022 | Thursday | News
Australia launches mobile service for mental healthcare

The Australian Government has announced the launch of the new Head to Health phone service which will help Aus...

August 23, 2022 | Tuesday | News
Hydrix receives approval for Guardian device in Singapore

Australia's Hydrix Limited has announced that the Health Services Authority of Singapore (HSA) has approved The Guardian...

August 23, 2022 | Tuesday | News
Long COVID-19 study in Australia identifies potential diagnostic and therapeutic targets

Australia-based Antisense Therapeutics has announced the outcomes from its collaboration to study the neurological aspec...

August 23, 2022 | Tuesday | News
Australia launches world-first preventative DNA screening for cancer, heart disease risk

The nationally collaborative project, led by Monash University and supported by researchers and clinicians across Austra...

August 22, 2022 | Monday | News
Australia invests $30 M to support vital brain and mental health research

Monash University has received a $30 million philanthropic gift that will fund vital mental health research and preventa...

August 19, 2022 | Friday | News